• The Charles Schwab Corporation’s Board of Directors has approved a 5 cent, or 19%, increase in its regular quarterly cash dividend to US$0.32 per common share, payable on February 27, 2026 to stockholders of record on February 13, 2026.
• This higher dividend, coming soon after strong 2025 earnings and a multi-billion-dollar share repurchase program, highlights Schwab’s continued emphasis on returning capital to shareholders.
• We’ll now examine how this sizable dividend hike, alongside recent buybacks, influences Charles Schwab’s broader investment narrative.

AI is about to change healthcare. These 111 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

What Is Charles Schwab's Investment Narrative?

To own Charles Schwab, you need to believe in its core as a scale brokerage and wealth platform that converts client trust into stable earnings and strong cash generation. The latest 19% dividend hike to US$0.32, coming on the heels of higher 2025 earnings and a completed US$5.45 billion buyback, reinforces that story of disciplined capital return rather than changing it. In the near term, the key catalysts still sit around balance sheet and net interest income trends, plus how effectively Schwab deepens relationships across brokerage, banking and advice as it reorganizes leadership in technology and wealth advisory. The bigger risk is that richer capital returns and leadership changes raise expectations at a time when revenue growth forecasts already trail the broader US market.

However, there is a funding and rate sensitivity angle here that investors should not ignore. Despite retreating, Charles Schwab's shares might still be trading above their fair value and there could be some more downside. Discover how much.

Exploring Other Perspectives

Seven fair value estimates from the Simply Wall St Community span roughly US$79 to US$121 per share, underscoring how differently investors view Schwab’s prospects. As you weigh those views against Schwab’s richer dividend and ongoing execution risks, it is worth comparing multiple angles before deciding how this story fits into your portfolio.

Explore 7 other fair value estimates on Charles Schwab - why the stock might be worth as much as 17% more than the current price!

Build Your Own Charles Schwab Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Charles Schwab research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Charles Schwab research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Charles Schwab's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 32 best rare earth metal stocks of the very few that mine this essential strategic resource.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.